Acadia Pharmaceuticals ACAD Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's change in other assets?
- Acadia Pharmaceuticals (ACAD) reported change in other assets of $32K in Q1 2026.
- How has Acadia Pharmaceuticals's change in other assets changed year-over-year?
- Acadia Pharmaceuticals's change in other assets decreased by 94.5% year-over-year, from $585K to $32K.
- What is the long-term trend for Acadia Pharmaceuticals's change in other assets?
- Over 2 years (2021 to 2025), Acadia Pharmaceuticals's change in other assets has grown at a 46.0% compound annual growth rate (CAGR), from -$1.8M to $3.85M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.